An Ever Growing Portfolio of Diverse Healthcare Companies

Engineers and develops therapeutic protease products

Emerging biopharmaceutical company which develops novel products to address unmet medical needs

Identifies novel anti-cancer agents that combine the efficacy of cytotoxics with the tumor cell selectivity of modern targeted therapeutics.

Develops innovative cardiovascular products

Develops complete human genome sequencing and analysis

Develops innovative therapeutics targeting cancer network disruption

Develops antibody-based therapies to treat infectious diseases.

Rapidly identifies human DNA

Developed a method to safely and more effectively deliver vaccines through the use of a skin patch and without injections

Develops and markets biologic products for the repair or replacement of damaged or inadequate tissues.

Develops a therapeutic platform that combines the best-in-class light activated drug and novel light generation devices to destroy tumors from the inside out

Develops drug candidates targeting indications in ophthalmology, inflammation and oncology, with a lead DARPin in clinical Phase I/IIa

Builds the first platform for generating human monoclonal antibodies using a transgenic rat

Develops instrumentation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to biomarker discovery and personalized medicine

Applies state-of-the-art semiconductor technology to the treatment of cardiovascular disease

Specialty oncology company which develops imaging and therapeutic products

Develops a method to produce antigen-specific human polyclonal antibody preparations

Develops and commercializes innovative therapies for the prevention and treatment of diseases with significant unmet medical need

Develops risk-sensitive in-licensed cancer drugs to address unmet medical needs